Pharma Forum

This event is over.

Purpose of the Event - A Burning Platform

Marketing in the pharmaceutical industry is rapidly transforming through technology, digital media, online video, mobile and more. At the same time, (and on an equally accelerated pace) it faces a myriad of ongoing regulatory complexities. As a result, perhaps no specialty in contemporary marketing has been challenged more than the sourcing and procurement of marketing services. That's why the ANA is bringing this group of specialists together again for another Pharma Forum -not only to catch-up to the pace of change, but to get in front of what's next.

Join us for this unique opportunity to engage directly with your peers about how they're taking on these challenges and get current on the regulatory environment from experts who are helping to drive the agenda.

Related Content


 9:00 am: Complimentary Networking Breakfast

 9:30 am: Welcome
& Introductions

 9:40 am: Morning Sessions

- Friends, tweets, profiles, avatars, blogs, chats, personalized pages, customized URLs-keeping up with social media can be daunting. Social media continues to change the rules of engagement for companies, brands, marketing professionals and their legal advisors. Just as marketing models are changing to take advantage of social media, industries must confront new and unprecedented legal risks in this brave new world of engagement-a world lawmakers, regulators and courts are struggling to figure out. This presentation will provide an overview of the legal landscape evolving around social media platforms as well as case studies of social media successes and failures and how it all relates to the pharmaceutical industry.

Keri Bruce, Associate, Reed Smith LLP
As an attorney, Keri represents advertisers, advertising agencies, media companies, talent payroll companies and trade associations on a wide range of advertising, promotion, marketing, technology and entertainment matters.


  • New Commercial Model: Understand the shift away from more traditional sales and marketing models in order to better connect with customers
  • Best practices in engaging consumers and healthcare professionals in a digital era

Dorothy Gemmell, Senior Vice President, Pharmaceutical and Medical Device Markets, WebMD

AGENCY RELATIONSHIP ISSUES - A presentation by the Sanofi Purchasing Team covering key agency issues from recent agency committee meetings.  This session will also facilitate an interactive discussion! 

Rich Sherwood, Procurement - North America, Sanofi


12:20 pm: Facilitated "Round table" Networking Lunch

This is what ANA does best! Your chance to meet and learn directly from your peers about the most important issues that are keeping us awake.

1:20 pm: Afternoon Sessions

MAKING MOBILE HAPPEN IN PHARMACEUTICAL MARKETING: Lessons-learned while establishing the mobile channel within the Pharma industry -
Pharmaceutical and healthcare companies have struggled to set on a clear path on the mobile marketing ground. Augme Technologies will share experiences while helping pharmaceutical marketers establish mobile marketing as a secure, compliant and sustainable channel. Featured examples will include learnings from product launches, developing successful relationships with mobile agencies, and navigating mobile through FDA, HIPPA and more.  

Mobile experts from Augme Technologies
Augme Technologies, Inc.
provides strategic services and mobile technology to leading consumer and healthcare brands. Augme also provides business to consumer utilities including national mobile couponing solutions, strategic mobile healthcare tools, custom mobile application development, consumer data tracking and analytics, creative execution, and mobile media planning.

If advertising is no longer tax deductible, what will happen to marketing and media? ANA's Dan Jaffe will discuss the status of the proposals to eliminate the tax deduction for DTC prescription drug advertising and efforts to place a moratorium on the advertising of new prescription drug products. Dan will also discuss the other legislative, regulatory and legal issues that impact directly or impinge on DTC or OTC drug advertising.

Dan Jaffe, Executive Vice President, Government Relations, ANA

3:30 pm: Meeting Adjourns